aTyr Pharma Announces Second Quarter 2015 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
aTyr Pharma (LIFE) Reports Q2 Loss of $0.74/Share
August 12, 2015 4:11 PM EDTaTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.74), versus ($6.85) reported last year.
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
... More